Sankar Shyam
- SEC CIK
- 0001824159
In the past year, 5 open-market sale filings worth $102.0M and no purchases.
Current role at each company
- PLTR Palantir Technologies Inc.See Remarksas of Aug 12, 2026
- DNA Ginkgo Bioworks Holdings, Inc.Directoras of Jun 13, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $102.0M
- 5 filings
- Net
- −$102.0M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sankar Shyam as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PLTR Palantir Technologies Inc.
See Remarks36 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 (view filing)8:01 PM ET | Aug 6 | 4 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −35.0K | $155.70 | −$5.45M | −5.2%642.8K after | 5 lots10b5-1 |
| Jul 7, 2026 (view filing)8:02 PM ET | Jul 2 | 5 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −35.0K | $130.00 | −$4.55M | −5.2%642.8K after | 10b5-1 |
| Jul 7, 2026 (view filing)8:02 PM ET | Jul 2 | 5 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −150.0K | $130.00 | −$19.5M | −20.0%599.9K after | 10b5-1 |
| May 22, 2026 (view filing) | May 20 | 2 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −165.5K | $136.04 | −$22.5M | −20.5%642.8K after | 5 lots |
| Feb 24, 2026 (view filing) | Feb 20 | 4 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −168.0K | $133.72 | −$22.5M | −20.7%642.8K after | 5 lots |
| Nov 24, 2025 (view filing) | Nov 20-21 | 4 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −168.9K | $163.12 | −$27.5M | −20.8%642.8K after | 22 lots |
| Aug 22, 2025 (view filing) | Aug 20-22 | 2 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −200.9K | $154.29 | −$31.0M | −22.2%702.8K after | 25 lots10b5-1 |
| Aug 22, 2025 (view filing) | Aug 20 | 2 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −375.0K | $151.20 | −$56.7M | −34.8%702.8K after | 14 lots10b5-1 |
| Jun 12, 2025 (view filing) | Jun 10 | 2 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −405.0K | $132.08 | −$53.5M | −36.6%702.8K after | 5 lots10b5-1 |
| May 22, 2025 (view filing) | May 20-21 | 2 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −167.5K | $126.35 | −$21.2M | −19.3%702.8K after | 7 lots |
DNA Ginkgo Bioworks Holdings, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2024 (view filing) | May 15 | 1 day | Sankar ShyamDirector | PPurchaseClass A Common Stock | +625.0K | $0.82 | +$512.5K | +36.1%2.36M after | |
| May 22, 2023 (view filing) | May 18 | 4 days | Sankar ShyamDirector | PPurchaseClass A Common Stock | +400.0K | $1.28 | +$512.0K | +30.0%1.73M after |